North America Point-of-Care Molecular Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Point-of-Care Molecular Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Point-of-Care Molecular Diagnostics Market Regional Analysis

6.2 North America Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 North America Point-of-Care Molecular Diagnostics Market Forecast Analysis

7. North America Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services

7.1 Assays and Kits

7.1.1 Overview
7.1.2 Assays and Kits: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Services and Software

7.3.1 Overview
7.3.2 Services and Software: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Point-of-Care Molecular Diagnostics Market Analysis – by Technology

8.1 PCR

8.1.1 Overview
8.1.2 PCR: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Isothermal Nucleic Acid Amplification Technology

8.2.1 Overview
8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Other Technologies

8.3.1 Overview
8.3.2 Other Technologies: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Point-of-Care Molecular Diagnostics Market Analysis – by Application

9.1 Infectious Diseases

9.1.1 Overview
9.1.2 Infectious Diseases: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Oncology

9.2.1 Overview
9.2.2 Oncology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Hematology

9.3.1 Overview
9.3.2 Hematology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Prenatal Testing

9.4.1 Overview
9.4.2 Prenatal Testing: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Endocrinology

9.5.1 Overview
9.5.2 Endocrinology: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.6 Other Applications

9.6.1 Overview
9.6.2 Other Applications: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Point-of-Care Molecular Diagnostics Market Analysis – by End User

10.1 Hospitals and Clinics

10.1.1 Overview
10.1.2 Hospitals and Clinics: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Diagnostic Laboratories

10.2.1 Overview
10.2.2 Diagnostic Laboratories: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Research and Academic Institutes

10.3.1 Overview
10.3.2 Research and Academic Institutes: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America Point-of-Care Molecular Diagnostics Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.1.2 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.1.3 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.1.4 US: North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.2 Canada: North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.2.2 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.2.3 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.2.4 Canada: North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.3 Mexico : North America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.3.2 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.3.3 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.3.4 Mexico : North America Point-of-Care Molecular Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 bioMérieux SA

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 F. Hoffmann-La Roche Ltd.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Danaher Corporation

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Enzo Biochem, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Abbott

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 binx health, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Meridian BioScience, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Biocartis

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Quidel Corporation

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Bio-Rad Laboratories, Inc.

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Point-of-Care Molecular Diagnostics Market